Loading...
Biogen Inc.
BIIB•NASDAQ
Healthcare
Drug Manufacturers - General
$131.52
$-1.07(-0.81%)
Biogen Inc. (BIIB) Financial Performance & Income Statement Overview
Review Biogen Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.62%
↓ 1.62%
Operating Income Growth
149.39%
↑ 149.39%
Net Income Growth
40.57%
↑ 40.57%
Operating Cash Flow Growth
85.85%
↑ 85.85%
Operating Margin
23.17%
↑ 23.17%
Gross Margin
75.58%
↑ 75.58%
Net Profit Margin
15.07%
↑ 15.07%
ROE
8.97%
↑ 8.97%
ROIC
10.002%
↑ 10.002%
Biogen Inc. (BIIB) Income Statement & Financial Overview
Review Biogen Inc.'s (BIIB) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.45B | $2.47B | $2.35B | $2.20B |
| Cost of Revenue | $0.00 | $638.70M | $704.80M | $689.80M |
| Gross Profit | $2.45B | $1.83B | $1.65B | $1.51B |
| Gross Profit Ratio | $1.00 | $0.74 | $0.70 | $0.69 |
| R&D Expenses | $532.30M | $542.70M | $442.00M | $383.60M |
| SG&A Expenses | $680.00M | $588.40M | $553.80M | $581.50M |
| Operating Expenses | $1.21B | $1.38B | $995.80M | $965.10M |
| Total Costs & Expenses | $2.16B | $2.01B | $1.70B | $1.65B |
| Interest Income | $0.00 | $11.60M | $20.10M | $17.40M |
| Interest Expense | $0.00 | $59.80M | $61.30M | $69.20M |
| Depreciation & Amortization | $0.00 | $182.80M | $158.80M | $147.60M |
| EBITDA | $0.00 | $693.60M | $918.80M | $681.60M |
| EBITDA Ratio | $0.00 | $0.28 | $0.39 | $0.31 |
| Operating Income | $1.24B | $496.40M | $652.40M | $545.40M |
| Operating Income Ratio | $0.51 | $0.20 | $0.28 | $0.25 |
| Other Income/Expenses (Net) | -$950.90M | -$45.40M | -$113.20M | -$80.60M |
| Income Before Tax | $291.50M | $451.00M | $698.70M | $464.80M |
| Income Before Tax Ratio | $0.12 | $0.18 | $0.30 | $0.21 |
| Income Tax Expense | $24.70M | $62.50M | $115.10M | $71.40M |
| Net Income | $266.80M | $388.50M | $583.60M | $393.40M |
| Net Income Ratio | $0.11 | $0.16 | $0.25 | $0.18 |
| EPS | $1.83 | $2.67 | $4.01 | $2.71 |
| Diluted EPS | $1.83 | $2.66 | $4.00 | $2.70 |
| Weighted Avg Shares Outstanding | $145.70M | $145.70M | $145.60M | $145.20M |
| Weighted Avg Shares Outstanding (Diluted) | $145.90M | $145.90M | $145.90M | $145.90M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan